<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE309nnn/GSE309461/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309461</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Bulk RNA sequencing of liver NK cells and ILC1s from T-bet WT vs. inducible Ncr1-T-bet Δ/Δ mice</name><description>The role of the T-box transcription factors T-bet and Eomes in innate lymphoid cells (ILCs) beyond their development is not well understood. We generated an inducible, NKp46 (Ncr1)-specific T-bet floxed knock-out mouse (Ncr1-T-betΔ/Δ) model. Bulk RNA sequencing of liver NK cells after tamoxifen treatment from T-bet WT (NKp46-CreERT2 x T-bet fl/fl) vs. Ncr1-T-bet Δ/Δ (NKp46-CreERT2 x T-bet fl/fl) mice had minimal transcriptional changes, whereas T-bet-deficient ILC1 exhibited significant gene expression changes. This sequencing data along with their rapid loss in vivo in Ncr1-T-betΔ/Δ mice reveal the requirement for continuous T-bet expression in liver ILC1.</description><dates><publication>2026/04/06</publication></dates><accession>GSE309461</accession><cross_references><GSM>GSM9267730</GSM><GSM>GSM9267721</GSM><GSM>GSM9267720</GSM><GSM>GSM9267731</GSM><GSM>GSM9267723</GSM><GSM>GSM9267722</GSM><GSM>GSM9267725</GSM><GSM>GSM9267724</GSM><GSM>GSM9267727</GSM><GSM>GSM9267716</GSM><GSM>GSM9267726</GSM><GSM>GSM9267729</GSM><GSM>GSM9267718</GSM><GSM>GSM9267717</GSM><GSM>GSM9267728</GSM><GSM>GSM9267719</GSM><GPL>34290</GPL><GSE>309461</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>